Literature DB >> 1326578

Comparison of tyrosine kinase activation by mitogenic and nonmitogenic anti-IgD antibodies.

M Brunswick1, A Burkhardt, F Finkelman, J Bolen, J J Mond.   

Abstract

Low concentrations of anti-Ig dextran conjugates that stimulate very high levels of B cell proliferation and Ig secretion stimulate no detectable increases in tyrosine phosphorylation. To study this point further, we compared tyrosine phosphorylation patterns induced by mitogenic and nonmitogenic anti-Ig antibodies. Whereas the mitogenic, strongly cross-linking, antibody H delta a/1 induced greater levels of tyrosine phosphorylation than did the nonmitogenic antibody FF1-4D5, the pattern of substrate phosphorylation was equivalent. At lower concentrations of H delta a/1, which were still mitogenic, the degree of phosphorylation that was induced was similar to that induced by high concentrations of FF1-4D5. Both antibodies stimulated comparable increases in the kinase activity of the three src-related kinases present in normal B cells and linked to the IgR, i.e., Blk, Fyn, and Lyn. These results suggest that the extent of tyrosine kinase activation is proportional to mIg cross-linking, that induction of B cell DNA synthesis may require little tyrosine kinase activation, and that activation of tyrosine kinase per se does not necessarily lead to B cell DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  The autoimmunity-associated BLK haplotype exhibits cis-regulatory effects on mRNA and protein expression that are prominently observed in B cells early in development.

Authors:  Kim R Simpfendorfer; Lina M Olsson; Nataly Manjarrez Orduño; Houman Khalili; Alyssa M Simeone; Matthew S Katz; Annette T Lee; Betty Diamond; Peter K Gregersen
Journal:  Hum Mol Genet       Date:  2012-06-07       Impact factor: 6.150

2.  Follicular dendritic cells in health and disease.

Authors:  Mohey Eldin M El Shikh; Costantino Pitzalis
Journal:  Front Immunol       Date:  2012-09-21       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.